The Consumer Financial Protection Bureau (CFPB) has recently implemented a final rule amending Regulation V, which impacts the Fair Credit Reporting Act. This regulation aims to shield consumers from the repercussions of medical debt by prohibiting creditors from assessing medical debt and lenders from considering medical information in their lending decisions. While the intention behind this rule is to alleviate the financial burden of medical debt on consumers, it does not eliminate the debt itself but rather obscures it. The article argues that this approach could lead to unintended consequences, such as incentivizing consumers to prioritize non-medical debts, ultimately harming their access to healthcare. Providers may shift to an upfront cash payment model, disadvantaging those with poor credit who cannot afford immediate payments. Furthermore, the article questions the urgency of addressing medical debt, noting that a significant portion is relatively low, suggesting that the CFPB's rule may exacerbate existing issues rather than resolve them.
Read the full article here.